FDA guidance addresses developing treatments for pediatric IBD
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyCDERClinical TrialsGuidancePediatric productsPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyCDERClinical TrialsGuidancePediatric productsPharmaceuticalsRegulatory Intelligence/PolicyUnited States